JPM: New Novartis pharma chief rethinks its drug-launch formula

Novartis CEO Vas Narasimhan said this week the company has to become a “launch machine” to make current and upcoming rollouts pay off. Key to that effort will be its pharma chief, Marie-France Tschudin, who's revamping its launch strategies for a new era.